Resmed Inc. buy UBS Group AG
Start price
24.04.25
/
50%
€207.50
Target price
24.04.26
€251.00
Performance (%)
2.41%
Price
07.01.26
€212.50
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG shows slight gains of 2.41%. This prediction currently runs until 24.04.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 1.918% | 1.918% |
| iShares Core DAX® | 2.462% | 4.579% |
| iShares Nasdaq 100 | 1.237% | -0.442% |
| iShares Nikkei 225® | 2.933% | 1.229% |
| iShares S&P 500 | 0.975% | 0.565% |
Comments by UBS_Group_AG for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target lowered by analysts at UBS Group AG from $290.00 to $285.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat